Thursday - April 17, 2025

University of Colorado Assigned Patent for Selective Inhibition of.Beta.1-adrenergic Receptors for Treatment of Pediatric Heart Failure

2016-10-06

ALEXANDRIA, Va., Oct. 6 -- The University of Colorado, Denver, has been assigned a patent (9,456,997) developed by three co-inventors for the "selective inhibition of.beta.1-adrenergic receptors for the treatment of pediatric heart failure." The co-inventors are Brian Stauffer, Aurora, Colorado, Carmen Sucharov, Aurora, Colorado, and Shelley Miyamoto, Aurora, Colorado.

The patent application was filed on Aug. 25, 2011 (13/817,969). The full-text of the patent can be found at http: . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

University of Colorado Assigned Patent for Selective Inhibition of.Beta.1-adrenergic Receptors for Treatment of Pediatric Heart Failure

Information Request Form

Copyright Targeted News Service 2016